PhoenixBio Competitors and Similar CompaniesClear all
PhoenixBio's competitors and similar companies include FibroGen, CanSino Biologics, SingletO2 Therapeutics and Worldwide Clinical Trials.
 PhoenixBio PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. |  CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  SingletO2 Therapeutics SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease. |  Worldwide Clinical Trials Worldwide Clinical Trials is a company that specializes in biotechnology and pharmaceutical research. | |
Founding Date | Founding Date 2002 | Founding Date 1993 | Founding Date 2009 | Founding Date 2015 | Founding Date 1986 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Higashihiroshima, JP HQ New York, US | Locations San Francisco, US HQ | Locations Tianjin, CN HQ | Locations Summit, US HQ | |
Employees | Employees 70 | Employees 53115% increase | Employees 1,10526% decrease | Employees 2 | Employees 3,5372% increase |
Valuation ($) | Valuation ($) 10.9 m | Valuation ($) 30.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥1.5b (FY, 2025) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥405.1m (FY, 2025) | Cost of goods $556k (FY, 2025) | Cost of goods ¥81.4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥1.1b (FY, 2025) | Gross profit $5.9m (FY, 2025) | Gross profit ¥1.1b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (¥448.9m) (FY, 2025) | Net income $183.5m (FY, 2025) | Net income ¥27.9m (FY, 2025) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
FibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View companyCanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View companySingletO2 Therapeutics
HQ
Summit, US
Employees
2
SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease.
View companyWorldwide Clinical Trials
HQ
Durham, US
Employees
3,537↑ 2% increase
Worldwide Clinical Trials is a company that specializes in biotechnology and pharmaceutical research.
View company